Canada pools resources in wide-ranging strategy:
This article was originally published in Clinica
Canada is to strengthen its resources to fight cancer with the implementation of a Canadian Strategy for Cancer Control (CSCC). The programme, which was launched in November 2006 and allocated Can$260m (US$241m) over five years, is currently in the planning process. It aims to effectively tap the country's knowledge bank to improve prevention, diagnosis and treatment of cancer. The CSCC is constituted of "key players" in several fields, including primary prevention, screening/early detection, surveillance, diagnostics and research. In 2007 it is predicted that Canada will see around 159,000 new cases of cancer and 72,700 deaths from cancer. Overall, lung cancer and colorectal cancer are, respectively, the leading and the second leading causes of death from cancer in Canada.
You may also be interested in...
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
While analysts are struggling to look further than generic competition facing the French firm's best-seller Somatuline, new chief David Loew tells Scrip that intelligent lifecycle management and focused external deals will drive Ipsen's growth.
Bridges Consumer Healthcare launched by former Sanofi executives gets its first brand by acquiring North American rights to Pfizer’s ThermaCare HeatWraps brand. Pfizer divested the brand so European regulators would give antitrust clearance to its consumer JV with GSK.